Clinical and prognostic significance of C-reactive protein in the conditions of stable angina pectoris in combination with chronic obstructive pulmonary disease stage II–III

Authors

DOI:

https://doi.org/10.14739/2310-1210.2023.5.283643

Keywords:

angina pectoris, chronic obstructive pulmonary disease, C-reactive protein, inflammation, troponin I, prognosis

Abstract

The aim of the study: to evaluate the clinical and prognostic value of the altered C-reactive protein expression level in functional class II–III stable angina pectoris combined with chronic obstructive pulmonary disease (COPD) stage II–III.

Materials and methods. In accordance with the goal of the study, 122 individuals were examined being assigned to 4 clinical groups: Group 1 – 30 patients with ischemic heart disease (IHD, functional class II–III stable angina pectoris, mean age 56.93 ± 1.25 years; male / female ratio 86.67 % / 13.33 %); Group 2 – 30 patients with COPD stage II–III (mean age 57.99 ± 1.12 years; male / female ratio 80.0 % / 20.0%); Group 3 – 40 patients with IHD + COPD (mean age 56.48 ± 1.16 years; male / female ratio 76.92 / 23.08 %) and Group 4 – 22 apparently healthy individuals (mean age 54.37 ± 1.84 years old, male / female ratio 77.50 % / 22.50 %).

Results. Significant correlations have been found between the level of C-reactive protein (CRP) and troponin I (r = +0.71 and r = +0.82, p < 0.01 for both pairs) in IHD and IHD + COPD groups. When the level of CRP expression was elevated, a clear increase in the level of cardiospecific proteins (troponin I) was seen, which could indicate a damage to the myocardium.

A positive association was found between the CRP level and the CAT scale score in COPD and IHD+COPD groups (r = +0.65 and r = +0.73, respectively, p < 0.05) indicating a significant association between the processes of systemic inflammation and the dynamics of a patient’s subjective condition, caused mainly by the severity of ventilatory and respiratory disorders and pulmonary obstruction.

The relative risk for cardiorespiratory fitness impairment (according to 6MWD) in patients with a high level of CRP (>6 mg/L) was almost 13 times higher (EER 80.0 % CER 6.25 %, RR = 12.8 at 95 % CI, which was 1.87–87.56, р < 0.001), while the odds ratio was 60 (OR = 60.0 with CI 4.69–767.85, р < 0.001), compared to patients with a CRP level <6 mg/L, indicating systemic inflammatory process progression in the development of a negative prognosis of IHD combined with COPD.

Conclusions. The study and examination of the CRP level is necessary as a prognostic predictor for assessing the risk for developing cardiovascular complications in ІHD combined with COPD.

Author Biographies

S. Ya. Dotsenko, Zaporizhzhia State Medical and Pharmaceutical University, Ukraine

MD, PhD, DSc, Professor, Head of the Department of Internal Diseases 3

О. О. Kraidashenko, Zaporizhzhia State Medical and Pharmaceutical University, Ukraine

Postgraduate student of the Department of Internal Diseases 3

References

  1. Ministry of Health of Ukraine. (2021, December 23). Pro zatverdzhennia Unifikovanoho klinichnoho protokolu pervynnoi, vtorynnoi (spetsializovanoi) ta tretynnoi (vysokospetsializovanoi) medychnoi dopomohy "Stabilna ishemichna khvoroba sertsia" [On the approval of the Unified clinical protocol of primary, secondary (specialized) and tertiary (highly specialized) medical care "Stable ischemic heart disease" (No. 2857)]. https://zakon.rada.gov.ua/rada/show/v2857282-21#n609
  2. Krakhmalova, O. O., Hetman, O. A., Kharchenko, Yu. Y., & Izmaylova, O. V. (2017). Dynamika ultrazvukovykh parametriv diastolichnoi ta systolichnoi funktsii sertsia u khvorykh na KHOZL ta suputniu IKHS v zalezhnosti vid vyboru bazysnoi terapii KHOZL ta naiavnosti pulmonalnoi reabilitatsii [Dynamics of ultrasound parameters of diastolic and systolic heart function in patients with COPD and concomitant coronary heart disease depending on the choice of basic COPD therapy and presence of pulmonary rehabilitation]. Ukrainskyi pulmonolohichnyi zhurnal, (4), 30-34. [in Ukrainian].
  3. Ministry of Health of Ukraine. (2013, June 27). Pro zatverdzhennia ta vprovadzhennia medyko-tekhnolohichnykh dokumentiv zi standartyzatsii medychnoi dopomohy pry khronichnomu obstruktyvnomu zakhvoriuvanni lehen [On the approval and implementation of medical and technological documents on the standardization of medical care for chronic obstructive pulmonary disease (No. 555)]. https://zakon.rada.gov.ua/rada/show/v0555282-13?lang=en#Text
  4. Pope, J. E., & Choy, E. H. (2021). C-reactive protein and implications in rheumatoid arthritis and associated comorbidities. Seminars in arthritis and rheumatism, 51(1), 219-229. https://doi.org/10.1016/j.semarthrit.2020.11.005
  5. Yao, Z., Zhang, Y., & Wu, H. (2019). Regulation of C-reactive protein conformation in inflammation. Inflammation research, 68(10), 815-823. https://doi.org/10.1007/s00011-019-01269-1
  6. Pathak, A., & Agrawal, A. (2019). Evolution of C-Reactive Protein. Frontiers in immunology, 10, 943. https://doi.org/10.3389/fimmu.2019.00943
  7. Herwald, H., & Egesten, A. (2021). C-Reactive Protein: More than a Biomarker. Journal of innate immunity, 13(5), 257-258. https://doi.org/10.1159/000519091
  8. Dyer, E. M., Waterfield, T., & Baynes, H. (2019). How to use C-reactive protein. Archives of disease in childhood. Education and practice edition, 104(3), 150-153. https://doi.org/10.1136/archdischild-2018-315079
  9. Bogner, J. R. (2021). C-reaktives Protein (CRP) : Serie Laborparameter, Folge 1 [C-reactive protein]. MMW Fortschritte der Medizin, 163(5), 52-53. https://doi.org/10.1007/s15006-020-9504-0
  10. Levinson, T., & Wasserman, A. (2022). C-Reactive Protein Velocity (CRPv) as a New Biomarker for the Early Detection of Acute Infection/Inflammation. International journal of molecular sciences, 23(15), 8100. https://doi.org/10.3390/ijms23158100
  11. Said, S., Pazoki, R., Karhunen, V., Võsa, U., Ligthart, S., Bodinier, B., Koskeridis, F., Welsh, P., Alizadeh, B. Z., Chasman, D. I., Sattar, N., Chadeau-Hyam, M., Evangelou, E., Jarvelin, M. R., Elliott, P., Tzoulaki, I., & Dehghan, A. (2022). Genetic analysis of over half a million people characterises C-reactive protein loci. Nature communications, 13(1), 2198. https://doi.org/10.1038/s41467-022-29650-5
  12. Agarwala, P., & Salzman, S. H. (2020). Six-Minute Walk Test: Clinical Role, Technique, Coding, and Reimbursement. Chest, 157(3), 603-611. https://doi.org/10.1016/j.chest.2019.10.014
  13. Ross, R., Blair, S. N., Arena, R., Church, T. S., Després, J. P., Franklin, B. A., Haskell, W. L., Kaminsky, L. A., Levine, B. D., Lavie, C. J., Myers, J., Niebauer, J., Sallis, R., Sawada, S. S., Sui, X., Wisløff, U., American Heart Association Physical Activity Committee of the Council on Lifestyle and Cardiometabolic Health, Council on Clinical Cardiology, Council on Epidemiology and Prevention, Council on Cardiovascular and Stroke Nursing, … Stroke Council (2016). Importance of Assessing Cardiorespiratory Fitness in Clinical Practice: A Case for Fitness as a Clinical Vital Sign: A Scientific Statement From the American Heart Association. Circulation, 134(24), e653-e699. https://doi.org/10.1161/CIR.0000000000000461
  14. Sundh, J., Ställberg, B., Lisspers, K., Kämpe, M., Janson, C., & Montgomery, S. (2016). Comparison of the COPD Assessment Test (CAT) and the Clinical COPD Questionnaire (CCQ) in a Clinical Population. COPD, 13(1), 57-65. https://doi.org/10.3109/15412555.2015.1043426
  15. Pohanka, M. (2022). Diagnoses Based on C-Reactive Protein Point-of-Care Tests. Biosensors, 12(5), 344. https://doi.org/10.3390/bios12050344
  16. Liu, T., Zhang, Q., Song, C., Siyin, S. T., Chen, S., Zhang, Q., Song, M., Cao, L., & Shi, H. (2022). C-reactive protein trajectories and the risk of all cancer types: A prospective cohort study. International journal of cancer, 151(2), 297-307. https://doi.org/10.1002/ijc.34012
  17. Puthucheary, Z., Tadié, J. M., & Patel, J. J. (2022). C-reactive protein in immunometabolism: spared from 'paying the piper'. Intensive care medicine, 48(1), 103-105. https://doi.org/10.1007/s00134-021-06586-w
  18. Singh, S. K., & Agrawal, A. (2019). Functionality of C-Reactive Protein for Atheroprotection. Frontiers in immunology, 10, 1655. https://doi.org/10.3389/fimmu.2019.01655
  19. Friend, S. F., Nachnani, R., Powell, S. B., & Risbrough, V. B. (2022). C-Reactive Protein: Marker of risk for post-traumatic stress disorder and its potential for a mechanistic role in trauma response and recovery. The European journal of neuroscience, 55(9-10), 2297-2310. https://doi.org/10.1111/ejn.15031
  20. Ullah, N., & Wu, Y. (2022). Regulation of Conformational Changes in C-reactive Protein Alters its Bioactivity. Cell biochemistry and biophysics, 80(4), 595-608. https://doi.org/10.1007/s12013-022-01089-x
  21. Rajab, I. M., Hart, P. C., & Potempa, L. A. (2020). How C-Reactive Protein Structural Isoforms With Distinctive Bioactivities Affect Disease Progression. Frontiers in immunology, 11, 2126. https://doi.org/10.3389/fimmu.2020.02126
  22. McFadyen, J. D., Zeller, J., Potempa, L. A., Pietersz, G. A., Eisenhardt, S. U., & Peter, K. (2020). C-Reactive Protein and Its Structural Isoforms: An Evolutionary Conserved Marker and Central Player in Inflammatory Diseases and Beyond. Sub-cellular biochemistry, 94, 499-520. https://doi.org/10.1007/978-3-030-41769-7_20
  23. Santonocito, C., Sanfilippo, F., De Locker, I., Chiarenza, F., Giacomo, C., Njimi, H., George, S., Astuto, M., & Vincent, J. L. (2022). C-Reactive protein kinetics after cardiac surgery: A retrospective multicenter study. Annals of cardiac anaesthesia, 25(4), 498-504. https://doi.org/10.4103/aca.aca_141_21
  24. Manolis, A. S., & Manolis, A. A. (2022). High C-Reactive Protein/Low Serum Albumin: A Hidden Villain in Cardiovascular Disease. Angiology, 73(9), 797-799. https://doi.org/10.1177/00033197221120135
  25. Ngwa, D. N., & Agrawal, A. (2019). Structure-Function Relationships of C-Reactive Protein in Bacterial Infection. Frontiers in immunology, 10, 166. https://doi.org/10.3389/fimmu.2019.00166
  26. Avan, A., Tavakoly Sany, S. B., Ghayour-Mobarhan, M., Rahimi, H. R., Tajfard, M., & Ferns, G. (2018). Serum C-reactive protein in the prediction of cardiovascular diseases: Overview of the latest clinical studies and public health practice. Journal of cellular physiology, 233(11), 8508-8525. https://doi.org/10.1002/jcp.26791

Downloads

Published

2023-09-28

How to Cite

1.
Dotsenko SY, Kraidashenko ОО. Clinical and prognostic significance of C-reactive protein in the conditions of stable angina pectoris in combination with chronic obstructive pulmonary disease stage II–III. Zaporozhye Medical Journal [Internet]. 2023Sep.28 [cited 2026May21];25(5):395-402. Available from: https://zmj.zsmu.edu.ua/article/view/283643

Issue

Vol. 25 No. 5 (2023)

Section

Original research

License

Authors who publish with this journal agree to the following terms:

Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.  Лицензия Creative Commons